SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$3.72B
This Quarter Return
+6.56%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.14B
AUM Growth
+$2.14B
(+2,069%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
95.24%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
701
New
636
Increased
22
Reduced
4
Closed
36
Top Buys
| 1 |
CVS Health
CVS
|
$41.5M |
| 2 |
Boeing
BA
|
$40.9M |
| 3 |
Pfizer
PFE
|
$40.7M |
| 4 |
Philip Morris
PM
|
$37.9M |
| 5 |
JPMorgan Chase
JPM
|
$35.5M |
Top Sells
| 1 |
Uber
UBER
|
$20.3M |
| 2 |
Workday
WDAY
|
$8.99M |
| 3 |
Ferguson
FERG
|
$8.32M |
| 4 |
ANSS
Ansys
ANSS
|
$5.21M |
| 5 |
Mercado Libre
MELI
|
$4.77M |
Sector Composition
| 1 | Healthcare | 16.3% |
| 2 | Industrials | 14.79% |
| 3 | Financials | 12.51% |
| 4 | Utilities | 10.01% |
| 5 | Technology | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
NewMarket
NEU
$7.77B
| $233K | 0.01% |
+367
| New | +$233K |
|
602
Ryan Specialty Holdings
RYAN
$7.24B
| $228K | 0.01% |
+4,100
| New | +$228K |
|
603
Cadre Holdings
CDRE
$1.25B
| $225K | 0.01% |
+6,223
| New | +$225K |
|
604
The RealReal
REAL
$879M
| $225K | 0.01% |
+57,592
| New | +$225K |
|
|
BFS
605
Saul Centers
BFS
$833M
| $224K | 0.01% |
+5,824
| New | +$224K |
|
|
HUYA
606
Huya Inc
HUYA
$785M
| $222K | 0.01% |
+48,771
| New | +$222K |
|
607
Kelly Services Class A
KELYA
$502M
| $221K | 0.01% |
+8,820
| New | +$221K |
|
608
Phillips Edison & Co
PECO
$4.42B
| $219K | 0.01% |
+6,100
| New | +$219K |
|
609
Rayonier Advanced Materials
RYAM
$373M
| $219K | 0.01% |
+45,751
| New | +$219K |
|
610
ODP
ODP
$610M
| $218K | 0.01% |
+4,100
| New | +$218K |
|
611
Erasca
ERAS
$454M
| $216K | 0.01% |
+104,691
| New | +$216K |
|
612
Luminar Technologies
LAZR
$112M
| $214K | 0.01% |
+108,410
| New | +$214K |
|
613
Fulgent Genetics
FLGT
$679M
| $213K | 0.01% |
+9,816
| New | +$213K |
|
614
Shenandoah Telecom
SHEN
$727M
| $211K | 0.01% |
+12,163
| New | +$211K |
|
615
Grindr
GRND
$3B
| $209K | 0.01% |
+20,625
| New | +$209K |
|
616
Organogenesis Holdings
ORGO
$653M
| $207K | 0.01% |
+72,929
| New | +$207K |
|
617
National Healthcare
NHC
$1.76B
| $206K | 0.01% |
+2,177
| New | +$206K |
|
618
QCR Holdings
QCRH
$1.33B
| $205K | 0.01% |
+3,380
| New | +$205K |
|
619
Summit Therapeutics
SMMT
$17.7B
| $202K | 0.01% |
48,877
-37,335
| -43% | -$155K |
|
620
MRC Global
MRC
$1.27B
| $201K | 0.01% |
+16,000
| New | +$201K |
|
|
FINV
621
FinVolution Group
FINV
$2.08B
| $196K | 0.01% |
38,884
| – | – |
|
622
Aemetis
AMTX
$161M
| $195K | 0.01% |
32,542
-6,938
| -18% | -$41.6K |
|
623
Taboola.com
TBLA
$991M
| $195K | 0.01% |
+43,897
| New | +$195K |
|
624
KalVista Pharmaceuticals
KALV
$678M
| $192K | 0.01% |
+16,179
| New | +$192K |
|
625
Lyell Immunopharma
LYEL
$213M
| $191K | 0.01% |
+85,751
| New | +$191K |
|